2-(3-Hydroxyadamantan-1-yl)-2-oxoacetic acid

Catalog No. :
ACSDEH517
CAS No. :
709031-28-7
Molecular Formula :
C12H16O4
Molecular Weight :
224.26

IUPAC Name:2-(3-hydroxyadamantan-1-yl)-2-oxoacetic acid

2-(3-Hydroxyadamantan-1-yl)-2-oxoacetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$81.00Login to see priceIn stockInquiry
5g95%$283.00Login to see priceIn stockIn stock
10g95%$480.00Login to see priceIn stockIn stock
25g95%$960.00Login to see priceIn stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Hydroxyadamantan-1-yl)-2-oxoacetic acid
IUPAC Name2-(3-hydroxyadamantan-1-yl)-2-oxoacetic acid
MDL No.MFCD13185913
Molecular FormulaC12H16O4
Molecular Weight224.26
SMILESO=C(O)C(C12CC3(O)CC(C2)CC(C3)C1)=O
InChI KeyUDKIRRNUAXWHTO-UHFFFAOYSA-N
Synonym3-hydroxy- α-oxoadamantane-1-acetic acid;6. 3-hydroxy- α-oxoadamantane-1-acetic acid;2-(3-Hydroxy-1-adamantyl)-2-oxoacetic acid;3-Hydroxy-alpha-oxotricyclo[3.3.1.13,7]decane-1-acetic acid;2-(3-HydroxyadaMantan-1-yl)-2-oxoacetic acid;Tricyclo[3.3.1.13,7]decane-1-aceticacid, 3-hydroxy-a-oxo-;Saxagliptin INT 4;hydroxy-α-oxoadamantane-1-acetic acid
CAS No.709031-28-7
PubChem CID10466193

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACSDEH517 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSDEH517 route product structure diagram
    ACSDEH517709031-28-7 In Stock
Inquiry

2. ACSDEH517 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSDEH517 route product structure diagram
    ACSDEH517709031-28-7 In Stock
Inquiry

Comments (0)